The independent source for health policy research, polling, and news.
281 - 300 of 112,399 Results
On Wednesday, the Department of Justice rolled out dozens of planned changes to federal gun regulations, including rolling back a Biden-era measure that sought to end the "gun show loophole."
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health topics.
The jury attributed 88% of the fault to the University of Kansas Hospital Authority and 12% of the fault to LivaNova USA Inc., the medtech company that manufactured the device that was used in Stephen Nolte's heart surgery at KU Med. This is one of more than two dozen lawsuits filed against the University of Kansas Hospital Authority and LivaNova, the Kansas City Star reports.
According to the Centers for Disease Control and Prevention, roughly a dozen of the 34 people who became ill are younger than 5. Also in the news: consequences of covid screening; a report on deaths related to hepatitis B and C; the dangers of chatbots and bioterrorism; and more.
FDA staff have expressed concerns about the use of camizestrant to treat metastatic breast cancer and capivasertib for patients with metastatic hormone-sensitive prostate cancer. The Oncologic Drugs Advisory Committee will vote on these two drug applications Thursday.
Despite pushback from some members, the reconstituted Interagency Autism Coordinating Committee also recommended the establishment of safety measures to protect people who wander from their caregivers and to encourage Medicaid to set guidelines for diagnosis and possible health risks, Stat reported.
But NBC News reports that hospital CEOs pushed back during the House hearing Tuesday, saying high costs were a product of factors including low reimbursement rates and their obligation to treat sicker and sometimes uninsured patients. Meanwhile, a Gallup poll finds a record 55% of Americans report that their financial situation is worsening.
The last step necessary to clear the way to a settlement was delivered via a criminal sentence Tuesday by U.S. District Judge Madeline Cox Arleo, resolving thousands of lawsuits, AP reports. As part of the deal, Purdue will cease to exist and will be replaced by a new company, Knoa Pharma, with the aim of combating the opioid crisis.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
At least three pharma firms — Novartis, Amgen, and Eli Lilly — say they're closer to unraveling the mystery of lipoprotein(a), which is a more dangerous cousin to LDL cholesterol. Diet and exercise don't influence lp(a) levels, CNBC reported, and there is currently no medication for it.
Gardener John Durnell in 2019 filed a lawsuit in state court claiming a chemical in the weedkiller caused his cancer. He won that case. Now, the federal government contends it isn't a state-level issue. A Supreme Court ruling in his favor could open Bayer, the maker of Roundup, up to a flood of lawsuits; a ruling against him could endanger similar claims against the company.
On Friday, Natrona County District Judge Dan Forgey granted a temporary restraining order against a new state law banning abortion after embryonic cardiac activity can be detected. Forgey claimed it was likely to be overturned on the grounds that it violates the state Constitution, which says competent adults have the right to make their own healthcare decisions, AP reported.
One outlier in the American Medical Association's analysis was California, Fierce Healthcare reports, where reported premiums were “significantly lower,” perhaps due to a state law capping noneconomic damages.
Texas, Florida, and Utah are experiencing large outbreaks, while pockets of infection are still popping up around the U.S. Plus, The Hill examines what the loss of the hepatitis B vaccine could mean for the country; Roll Call looks at hepatitis C's grip on America; and more.
The federal government has paid to supply the test strips, which also check for other contaminants, to states since 2021, but the Trump administration now contends that harm-reduction measures encourage drug use, The New York Times reports. Experts assert that more information is better, and the distribution of test strips can stave off overdoses and encourage people who use drugs to exercise more caution.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
© 2026 KFF